Medicines and Related Substances Control Amendment Act
This section amends several definitions in the principal medicines law and allows international tendering for medicines under prescribed conditions.
AI-assisted research synopsis — verify against the official legal text below.
- Jurisdiction
- South Africa
- Instrument
- Act or statute
- Citation
- Act 90 of 1997
- Version
- Undated source snapshot
- Language
- en
- Updated
- Official source
- View official record ↗
Publicly available, excluded from search-engine indexing
This page remains available for direct access and API use, but this release emits
noindex,follow for the following reason:
- The record does not meet this release's canonical indexing criteria.
(market-indexing-disabled)
Statute overview
About this statute
This section amends several definitions in the principal medicines law and allows international tendering for medicines under prescribed conditions. This provision amends section 2 by adding a subsection stating that the council is a juristic person. This section replaces section 3 of the principal Act with a new section titled “Constitution of council”. The Minister may determine and appoint the number of council members, and the council must not have more than 24 members. Council members are appointed for five years, and expired members may be reappointed unless they have already served two five-year periods.
Search within this statute
Search all stored provisions in this version.
Legal text
Provisions of Medicines and Related Substances Control Amendment Act
Showing 39 of 39
- 1 Verify source ↗
Section i of the Medicines and
AI-assisted research summary: This section amends several definitions in the principal medicines law and allows international tendering for medicines under prescribed conditions.
1. Section i of the Medicines and referred to as the principal Act), is hereby amended— , r“ 4 No. 18505 GOVERNMENT GAZETTE. 12 DECEMBER 1997 Act No. 90, 1997 NIEDICINES AND REL.4TED SUBSTANCES CONTROL AMENDMENT ACT, 1997 (a) by the substitution in subsection ( 1 ) for the definition of “approved name” of the following definition: “ ‘approved name’. in relation to a medicine. means the [internationally recognized] international nonproprietary name (INN ) of such medicine or. where no such name exists, such other name as the council may determine. not being a brand name or trade name registered in terms of the Trade Marks Act. [1963 (Act No. 62 of 1963)] 1993 (Act No. 194 of ~;”’: (b) by the substitution in subsection ( 1 ) for the definition of “dentist” of the following definition: 5 10 “ ‘dentist’ means a person registered as such under the [Medical] Health Professions Act. 1974:”: (c) by the substitution in subsection ( 1 ) for the definition of “Director-General” of the following definition: “ ‘Director-General’ means the Director-General: [National] Health [and Population Development];”: 15 (d) b} the insertion in subsection ( 1 ) after the definition of “inspector” of the following definition: “’ ‘interchangeable multi-source medicine’ means medicines that contain the same active substances which are identical in strength or concentra- tion. dosage form and route of administration and meet the same or comparable standards. which compl~’ with the requirements for thera- peutic equivalence as prescribed;”; 20 (e) b> the deletion in subsection ( 1 ) of the definition of “Medical Act”: ($ b} the substitution in subsection (1) for the definition of “medical 25 practitioner” of the following definition: “ ‘medical practitioner’ means a person registered as such under the [Medical] Health Professions Act. 1974. and includes an intern registered under tha[ Ac[:” : (s) b! the substitution in subsection ( 1 ) for the definition of “Minister” of the 30 following definition: “ ‘Minister’ means the Minister of [National] Health:”; (/7) b} the insertion in subsection (1) after the definition of “pharmacist” of the following definitions: “ ‘pharmacist intern’ means a person registered as such under the Pharmacv Act. 1974: ‘pharmacist’s assistant’ means a person registered as such under the Pharmacy Act. 1974:”’: (i) b> the substitution in subsection ( 1 ) for the definition of “practitioner” of the folloving definition: “ “practitioner’ means a person registered as such under the [Associated] Chiropractors. Homeopaths and Allied Health Service Professions Act. 1982 (Act No, 63 of 1982);”; (j) by the substitution for subsection (2) of the following subsection: “(2) Subject to section 15C. [A] a medicine shall. notwithstanding the fact that its components are identic~l to those of any other medicine as to physical characteristics, quantity and quality. for the purpose of this Act not be regarded as being the same medicine as that other medicine if registration thereof is not applied for by the holder of the certificate of registration issued in respect of that other medicine.”; and (L) by tbe addi[ion of the following subsection: “(4) International tendering for medicines shall be allowed in the prescribed manner and on the prescribed conditions.”. 35 40 45 50 Amendment of section 2 of Act 101 of 1965, as amended by section 2 of Act 94 of 1991 55 - 2 Verify source ↗
Section 2 of the principal Act is hereby amended b) the addition of the following
AI-assisted research summary: This provision amends section 2 by adding a subsection stating that the council is a juristic person.
2. Section 2 of the principal Act is hereby amended b) the addition of the following subsection: “(3) The council shall be a juristic person. ” f! No 18505 GO\’ERNMENT GAZETTE, 12 DECEMBER 1997 Act No. W, 1997 h’tEDICINES AND REL.4TED SL’BSTANCES CONTROL AMENDMENT ACT. 1997 Substitution of section 3 of Act 101 of 1965, as amended by section 3 of Act 65 of 1974, section 1 of Act 36 of 1977, section 2 of Act 17 of 1979, section 46 of Act 97 of 1986 and section 3 of Act 94 of 1991 - 3 Verify source ↗
The following section is hereby substituted for section 3 of the principal Act:
AI-assisted research summary: This section replaces section 3 of the principal Act with a new section titled “Constitution of council”.
3. The following section is hereby substituted for section 3 of the principal Act: “Constitution of council 5 - 3 Verify source ↗
The council shall consist of so many members. but not more than 24.
AI-assisted research summary: The Minister may determine and appoint the number of council members, and the council must not have more than 24 members.
3. The council shall consist of so many members. but not more than 24. as the Minister ma} from time to time determine and appoint,”, Amendment of section 4 of Act 101 of 1965, as amended by section 4 of Act 65 of 1974 - 4 Verify source ↗
Section 4 of the principal Act is hereby amended by the substitution for subsections 10
AI-assisted research summary: Council members are appointed for five years, and expired members may be reappointed unless they have already served two five-year periods.
4. Section 4 of the principal Act is hereby amended by the substitution for subsections 10 ( 1 ) and (2) of the following subsections respectively: “(1 ) A member of the council shall. subject to the provisions of section 6(3). be appointed for a period of five years but a n~w council-shall be appointed within six months after the date of commencement of tbe Medicines and Related Substances Control Amendment Act. 1997. (2) Any person whose period of office as a member of the council has expired. shall be eligible for reappointment: Provided that no person who has served two periods of five vears as a member shall be so eligible.”. 15 Substitution of section 6 of Act 101 of 1965, as amended by section 5 of Act 65 of 1974, section 3 of Act 17 of 1979, section 46 of Act 97 of 1986 and section 4 of Act 20 94 of 1991 - 5 Verify source ↗
The following section is hereby substituted for section 6 of the principal Act:
AI-assisted research summary: Some people may not be appointed to the council, members can lose office if disqualified or otherwise listed events occur, and members must disclose interests and recuse themselves from related decisions.
5. The following section is hereby substituted for section 6 of the principal Act: “Disqualifications. vacation of office, filling of vacancies and declara- tion of interest 6. ( 1 ) NO person shall be appointed m a member of the council— 25 (a) who is an unrehabilitated insolvent: (b) who is disqualified under the Veterinq and Para-Veterinan Profes- sions Act. 1982, the Chiropractors, Homeopaths and Allied Health Serxice Professions Act. 1982. the Health Professions Act, 1974. or the Pharmacy Act. 1974. from carn>ing on his or ber profession. while so disqualified: (c) who is not a South African citizen permanently resident in the Republic; or (d) who is employed in the pharmaceutical indust~. (2) A member of the council shall vacate his or her office— ((7) (b) ((”J (d) (e) (f) if he or she is or becomes subject to an>’ disqualification referred to in subsection ( 1); if he or she ceases to hold an! qualification necessary for his or her appointment; if he or she becomes mentall} ill, as defined in the Mental Health Act. 1973 (Act No. 18 of 1973); if he or she is convicted of an offence and is sentenced to imprisonment without the option of a fine; if he or she has been absent from more than two consecutive meetings of the council without the council’s leave; or if the Minister is satisfied that the member has violated the internal rules of conduct as determined by the council and published b) notice in the Ga:ette. (3) If the office of an~ member becomes vacant before the expiration of the period for which he or she was appointed. the Minister may. subject to the provisions of section 3, appoint another person to hold office for the unexpired portion of the period for which his or her predecessor was appointed. 30 35 40 45 50 (4) A member of the council or of a committee appointed in terms of section 9 shall declare his or her commercial interests related to the 55 8 No. 18505 GOVERNMENT GAZETTE. 12 DECEhfBER 1997 Act No. 90.1997 hlEDICf XES AND REL.ATED SLWSTANCES COXTROL AMENDMEXT ACT 199: pharmaceutical m health care industry. which interests shall include. bu[ I shall not be limited to, any consultancy. paid or unpaid. any research grant from which the member directly or indirectly benefits. or an> equity holding or an~ executive or non-executive directorship or an> other payment or benefit in kind. and shall recuse himself or herself from an! discussion or decisiommaking to which the said interests relate or ma! relate.”’. 5 Amendment of section 9 of Act 101 of 1965, as amended by section 7 of Act 65 of 1974 - 6 Verify source ↗
Section 9 of the principal Act is hereby amended b! [he substitution for paragraph
AI-assisted research summary: This section amends section 9 of the principal Act, replacing paragraph (a) about how an executive committee is formed and approved.
6. Section 9 of the principal Act is hereby amended b! [he substitution for paragraph I o (a) of subsection ( 1 ) of the following paragraph: “(a) subject to the app roval of the Minister. from among its members an execu[i!e committee [the majority of the members of which shall be persons appointed in terms of paragraphs (a) and (c) of subsection (2) of section three]: and’”. Amendment of section 12 of Act 101 of 1965, as substituted by section 10 of Act 65 of 1974 - 7 Verify source ↗
Section 12 of the principal Ac[ is hereb) amended b} the substitution for subsection
AI-assisted research summary: The Minister may appoint and revoke the appointment of the Registrar of Medicines, after consulting the council and subject to public service laws.
7. Section 12 of the principal Ac[ is hereb) amended b} the substitution for subsection ( I ) of the following subsection: ‘“( 1 ) The Minister ma}. sut>iect to the laws governing the public service and aftel- consultation with the council. appoint and revoke such appointment of an officer to be styled the Registrar of Medicines, who shall perform the functions and cam! out the duties assigned to or imposed upon the registrar by or under this Ac[ and such other functions :ind duties as ma! from time to time be assigned to or imposed upon him or her b} the Minister or the Director-General.”. Amendment of section 14 of Act 101 of 1965, as amended by section 1 of Act 29 of 1968. section 12 of .4ct 65 of 1974, section 6 of .Act 17 of 1979 and section 7 of .Act 94 of 1991 - 8 Verify source ↗
Sec[ion 14 of the principal Act is hereby amended-
AI-assisted research summary: Subsection (1) does not apply to certain medicine sales when the medicine is compounded by specified professionals and meets listed conditions.
8. Sec[ion 14 of the principal Act is hereby amended- (a) b) the substitution for subsection (4) of the follouing subsection: ‘“(4 ~ The pro~isions of subsection ( 1 ) shall I1O[ appl~ in respect of the sale of an~ medicine— (a) - (b) compounded in the course of carrying on his or her professional activities b! a [medical practitioner] pharmacist. [practitioner or] veterinarian or person who is the holder of a Iicence contemplated in section WC( I )( fl). for a particular patient in a quantity not greatel- [htin [he -- quantit! required for treatment as determined b} the medical practitioner. pharmacist. practitioner or veterinarian: or compounded b} a pharmacist in a quantit! not greate]- than that prescribed b} regulation for sale in the retail trade. subject to the conditions likewise prescribed or in a quantity for a particular person or animal as prescribed b> a medical practitioner or a dentist or a veterinarian or a practitioner or a nurse or other person registered under the Health Professions Act, 1974. and referred to in section 22A. as the case ma} be, if such medicine does not contain any component tbe sale of which is prohibited by this Actor any component in respect of which an application for registration has been rejected. and is not or has not been advertised: Provided that the active components of such medicine appear in another medicine which has been registered under this Act.”: and (b) by the deletion of subsection (5). Amendment of section 15 of Act 101 of 1965, as amended by section 2 of Act 29 of 1968, section 13 of Act 65 of 1974 and section 8 of Act 94 of 1991 - 9 Verify source ↗
Section } 5 of the principal Act is hereb~ amended—
AI-assisted research summary: The registrar must send applications and supporting material to the council, tell the applicant in writing, and later publish prescribed particulars; the council can require expedited procedures, impose conditions, and direct registration subject to conditions.
9. Section } 5 of the principal Act is hereb~ amended— ]S 20 25 30 35 40 45 50 10 No. 18505 GOVERNMENT G.4ZETTE. 12 DECEhfBER 1997 ,4ct No. 90, 1997 M E D I C I N E S <’iND REL.4TED S[’BSTANCES cO~TRol. ,AMENDMENT ,ACT. 1997 (a) by the substitution for subsection (2) of the following subsection: “(21 The registrar shall— QJ as soon as possible after receipt b! him or her of an! such application submit the application together with any particulars and samples which accompanied the application to the council for 5 consideration and shall simultaneous]) inform the applicant in writing that the application has been so submitted: (b} ensure that such an application in respect of medicine which appears on the latest Essential Drug List or medicine which does not appear thereon but which. in the opinion of the Minister. is essential for national health ]s subject to such procedures as ma! be I prescribed in order to expedite the registration.”: (h) by the substitution for paragraph (b) of subsection (3) of the following I () paragraph: “(b) If the council is not so satisfied it shall cause the applicant [o be 15 notified in v,riting of the reasons wh~ it is not so satisfied and cause tbe applicant to be informed that he or she ma! within a period of one month after the dale of the notification furnish the registrar with his or her comments on the council’s reasons for not being so satisfied.”: (c) b) tbe substi[u[ion for subsection (7) of the fol]oving subsection: “(7 ) An) registration under this section. lncludin~ the registration of medicines alread} re~istered. shall be \’slid for a period of five Years and may be made subject to such conditions as ma} v,ith [due] regard to the succeeding provisions of this section be determined b) the council.”: (d) b~ the substltu[ion for subsection (9] of the following subsection: 20 25 “(9) If no such representations are lodged with the registral- b! the applican[ concerned uvthln a period of one month after the receipt by him or her of an) notification referred to in subsection (8). or if aftel- considera[ion of an} such representations the council is still of the opinion [hat the condition in question should be imposed. the council 30 shall direct [he re:istrm (o register the [relevant] medicine concerned subject to the said condition,”: (c) b> the substitution for subsection ( 11 ) of the following subsection: “( 11 ) The I-egistrar shall as soon as possible af[er the date of explr} of the appropriate period referred to in section 14(3) publish in the Gn;crfc 35 the presmibed particulars in respect of all applications for registration received b! him or her prior to such date.”: and (,f) by the addition of the foliov itlg subsection: “( 12) For tbe put-poses of this section. ‘Essential Dru~ List’ means the list of essential dmm included in the latest edition of the ofljcial 40 publication relatins to guidelines for standard treatment which is compiled b\ the Department of Health,”. Insertion of section 15C in Act 101 of 1965 - 10 Verify source ↗
The following section is hereb! inserted in the principal Act after section 15B:
AI-assisted research summary: This section inserts a new provision about measures to ensure the supply of more affordable medicines.
10. The following section is hereb! inserted in the principal Act after section 15B: “NIeasures to ensure supply of more affordable medicines - 15C Verify source ↗
The Minister ma> prescribe conditions for the suppl\ of more
AI-assisted research summary: The Minister may set conditions for supplying more affordable medicines, limit certain patent effects for medicines already on the market with the owner’s consent, and set conditions, registration procedures, and use rules for certain imported medicines.
15C. The Minister ma> prescribe conditions for the suppl\ of more affordable medicines in certain circumstances so as to protecl the health of the public. and in particular may— (a) notwithstanding anything to the contrary contained in the Patents Act. 1978 (Act No. 57 of 1978). determine that the rights with regard to any medicine under a patent granted in the Republic shall not extend to acts in respect of such medicine which has been put onto the market b> the ovner of the medicine. or with his or her consent; (b) prescribe the conditions on which any medicine which is identical in composition, meets the same quality standard and is intended to have the same proprietary name as that of another medicine already 45 50 55 .— -- . . .. —-— .. —.—,. . . . . . . . .-...——-.. . . . . . . . ,. .- . -.— -- 12 No. 18505 GOVERNNIENT GAZE’tTE. 12 D E C E M B E R 1997 Act NO. !)0, 1997 NIEDICIXES ,A..ND RELATED slJBsTA~CES CONTROL AhlENDMENT .4 CT. 1997 registered in the Republic. but which is imported by a person other than the person who is the holder of the registration certificate of the medicine already registered and which originates from any site of manufacture of the original manufacturer as approved by the council in the prescribed manner, may be imported; 5 (c) prescribe the registration procedure for. as well as the use of. the medicine referred to in para,~raph (b).”, Amendment of section 18 of Act 101 of 1965, as substituted by section 7 of Act 17 of 1979 - 11 Verify source ↗
Section 18 of the principal Act is hereby amended by the addi[ion of the following 10
AI-assisted research summary: The council must approve certain labels, and it may allow deviations from the prescribed label format and contents. The Minister may also set extra labelling requirements for medicines.
11. Section 18 of the principal Act is hereby amended by the addi[ion of the following 10 subsections: “(3) The label referred to in subsection ( 1 ) shall be approved by the council. (4) The council may authorise a deviation from the prescribed format and contents of an> label. (5) The Minister may prescribe additional requirements for the Iabelling of 15 medicines.”. Insertion of sections 18A, 18B and 18C in Act 101 of 1965 - 12 Verify source ↗
The following sections are hereb) inserted in the principal Act after section 18:
AI-assisted research summary: This section says new sections are inserted into the principal Act after section 18.
12. The following sections are hereb) inserted in the principal Act after section 18: “’Bonusing - 18A Verify source ↗
No person shall suppl~ an\ medicine according to a bonus svstem. 20
AI-assisted research summary: No person may supply a medicine through a bonus, rebate, or other incentive scheme, and no person may sample any medicine.
18A. No person shall suppl~ an\ medicine according to a bonus svstem. 20 rebate svstem or any other incentive scheme. Sampling of medicines 18B. ( 1 ) No person shall sample any medicine, (2) For the purposes of this section ‘sample’ means the free supply of medicines b~ a manufacturer or wholesaler or its agent to a pharmacist. medical practitioner. dentist. veterinarian. practitioner, nurse or other person registered under the Health Professions Act, 1974. but does not include the free supply of medicines for the purposes of clinical trials. donations of medicines to the State. tendering to the State and qualit~ control by inspectors. (3) The use of medicines or Scheduled substances for exhibition purposes shall be as prescribed. Code of ethics - 18C Verify source ↗
The Minister shall. after consultation with the pharmaceutical
AI-assisted research summary: The Minister must, after consulting the pharmaceutical industry and other stakeholders, prescribe a code of ethics for pharmaceutical companies’ marketing policies.
18C. The Minister shall. after consultation with the pharmaceutical industr} and other stakeholders. prescribe a code of ethics relatin~ to the 35 marketinz policies of pharmaceutical companies.”’. Substitution of section 22A of Act 101 of 1965, as inserted by section 21 of Act 65 of 1974 and amended by section 9 of Act 17 of 1979 - 13 Verify source ↗
The following section is hereby substituted for section 22A of the principal Act:
AI-assisted research summary: This section controls who may sell, possess, manufacture, import, export, or supply medicines and scheduled substances, and it sets permit, prescription, record-keeping, and timing rules.
13. The following section is hereby substituted for section 22A of the principal Act: “Control of medicines and Scheduled substances 22A. ( 1 ) Subject to this section. no person shall sell. have in his or her possession or manufacture any medicine or Scheduled substance. except in accordance with the prescribed conditions. (2) The Minister may, on the recommendation of the council. prescribe the Scheduled substances referred to in this section. (3) Any Schedule O substance may be sold in an open shop, (4) Any Schedule I substance shall not be sold— (a) by any person other than— 40 45 I 14 No 18505 GO\ ’ERX\lENT G.4Z13TE. 12 DECEMBER 199? Act 5io. 90.1997 MEDICINES ,\XD RELATED SUBSTANCES COXTR()[. ,.\hlENDhf EXT ..\ CT. 1$)9; (i) a pharmacist. or a pharmacist intern or pharmacis[’s assistan acting under the personal superl’ision of a pharmacist: (ii) a manufacturer of or wholesale dealer in pharmaceutical product for sale to any person who ma} luwf’rrlly possess such substance (iii) a medical practitioner or dentist. who may— 5 (aa ) prescribe such subscmce: (bb) compound and dispense such substance onl! if he 01- she i: the holder of a licence as contemplated in sectior ??c( l)(a): (if) a veterinarian u>ho ma! prescribe. compound or dispense SUC1 1() substance: ( \ ) a practitioner, nurse or a person registered under the Healtt Professions Act. 1974. other thm a medical prac(irioner 01 dentist. Who n~a~- (UJ) prescribe on]) the Scheduled substances identified in the Schedule for that purpose: (bb) compound and dispense the Scheduled substances referred to in i[em (aa) onl> if he or- she is the holder of a licencc contemplated in secrion XC( I )(a): (12) to an! person apparentl! under the age of 14 years except upon a prescription iisrred b> an authorised prescribe]- and dispensed b! a pharmacist. pharmacist intern or phartnacis(’s assistant or by a veterinarian or a person who is the holder of a licence as contemplated in sec[]on 22C’( I )(a). or on a uri[tcn order disclosing the purpose for which such subs[ance is to be used and bears a signature knov’n to the seller as the signa[ure of a person knov’n to such seller and who is apparent]! ol el- the age of 14 years: (c) unless the seller. other than a manufacturer or who)esale dealer in pharmaceutical pmduc[s. enters in ti prescription book required to be kept in the prescribed rnannel-. the prescribed particulars of such sale. (5) An> Schedule 2. Schedule 3. Schedule 4. Schedule 5 or Schedule 6 (b substance shall not be sold b! an! person other than— (a) a phammcist. pharmacist intern or a pharmacist’s assistanr acting under the personal supervision of a pharmacist, who ma! sell only Schedule 2 substances without a prescription; J pharmacls[ m a pharmacis[ in[em m pharmacist’s assistant acting under the personal super~, ision of a pharmacist. upon a written pre- scription issued b) an authorised prescriber or on the verbal instruc- tions of an authorised prescriber who is known to such pharmacist: a manufacturer of or wholesale dealer in pharmaceutical products for sale to an) person who ma! lauful]! possess such substance: ((’, (d) a medical practitioner or dentist. vho nlay- (i) prescribe such substance: (ii ) compound or dispense such subs[ance on]} if he or she is [he holder of a Iicence as contemplated in section 22C( 1 )(a): (e) a veterinarian who ma)’ prescribe. compound or dispense such substance: (f) a practitioner-. a nurse or a person registered under the Health Professions Act. 1974. other than a medical practitioner or dentist. who ma>- (i) prescribe onl) the Scheduled substances identified in the Schedule for that purpose: (ii) compound and dispense the Scheduled substances referred to in subparagraph (i) only if he or she is the holder of a licence contemplated in section UC( 1 )((//: (6) Any sale under subsection (5) shall only take place on condition that— (a) all the prescribed particulars of even sale shall be recorded in the prescribed manner in a prescription book or other permanent record required to be kept in the prescribed manner: (b) the authorised prescriber who has given verbal instructions to a pharmacist to dispense a prescription shall within seven days after giving such instructions furnish such phar-macis[ with a prescription confirming such instructions; IS !0 ! .5 10 if o 5 0 5 0 65 I (1 No, 18505 GO\’ERNMENT GAZEITE. 12 D E C E M B E R 1997 Act No. 90, 1997 MEDICINES AND RELATED SL’BSTANCES CONTROL .4klE,NDMENT ,4 CT, 1997 (c) (d) (e) (t) (,<) (/1) (i) (,;) in the case of verbal instructions the treatment period shall not excee~ seven days; if a prescription is not presented for dispensing within 30 days of issul it shall not be dispensed; in the case of a Schedule 2 substance. such substance ma! not b{ supplied to any person apparently under the age of 14 years excep upon a prescription issued b> an authorised prescriber and dispensef b) a pharmacist, pharmacist intern or pharmacist’s assistan[ or by i veterinarian or a person who is the holder of a licence as contemplate in section 22C( 1 )(a), or on a written order disclosing the purpose fo which such substance is to be used and bears a signature known to thf seller as the signature of a person known [o such seller and who i! apparently over the age of 14 years; in the case of a Schedule 2. Schedule 3 or Schedule 4 substance. suet sde ma) be repea[ed if the person who issued the prescription ha! indicated thereon (he number of times it may be dispensed. but not fo] longer than six months; in the case of a Schedule 5 substance. such sale shall not be repeatec for longer than six months, and then onlj if the authorised prescribe] has indicated on the prescription the number of times and the interval! at which it may be dispensed; where a Schedule 5 substance is used for— (i) its anxiolytic. antidepressant or tranquillisin,g properties it shal not be prescribed for longer than six months unless the authorisec prescriber has consulted a registered psychiatrist. or, in the case of a psychiatrist. another psychiatrist before issuing a new prescription: (ii ) its analgesic properties it shall not be prescribed for longer thar six months unless the authorised prescriber has consulted anotheI medical practitioner. before issuing a new prescription: in the case of a Schedule 6 substance. it shall not be repeated uithou[ a new prescription being issued: in an emergent! in which the health or life of a patient is at stake. a pharmacist engaged in whoiesale practice ma!. on receipt of a telephonic or telefaxed or other electronic request. supply a Schedule 6 substance to a pharmacist. medical practitioner. dentist, veterinarian. practitioner. nurse or other person registered under the HeaItb Professions Act. 1974. without a written order: Provided that— (i) it shall be the responsibility of such pharmacist. medical practitioner. dentist. veterinarian. practitioner. nurse or other person to ensure that such pharmacist recei~es a written order within seven days, (ii ) the Schedule 6 substance shall be supplied in the smallest unit sales pack available; (k) (1) (iii ) a permanent record is made and kept of such supply. in an emergency a pharmacist may sell any Schedule 5 or Schedule 6 substance in a quantity not greater than that required for continuous use for a period of 48 hours, on the verbal instructions of a medical practitioner. dentist. veterinarian. practitioner, nurse or other person registered under the Health professions Act, 1974, who is known to such pharmacist, but the prescriber who has given such verbal instructions shall within 72 hours after gi~’ing such instructions furnish to such pharmacist a written prescription confirming the instruc[icms: in an emergency a pharmacist may sell a Schedule 2, Schedule 3 or Schedule 4 substance on a non-recurnng basis for a period not exceeding 30 days in accordance with the original prescription in order to ensure that therapy is not disrupted if he or she is satisfied that an authorised prescriber initiated the therapj. with the intention that 18 No 18505 GO\’ERNMENT GAZETTE. 12 DECEMBER 1997 Act No. w. 1997 \lf3DIClNES AND REL.4TED SUBSTANCES CONTROL AMENDMENT ACT. 1997 ( m) (11) (()) ([) ) ((/) (r) the therap> be continued. and that the particulars of such sale at recorded in a prescription book or other prescribed permanent recorx a pharmacist may sell a greater or a lesser quantity of a Schedule Schedule 2. Schedule 3 or Schedule 4 substance than the quantit prescribed or ordered, according to the therapeutic pack in the origin: container of such substance as supplied to him or her. but the quantit so sold shall not exceed or be less than. 25 per cent of the quantit specified in the prescription or order in question; any seller referred to in this subsection shall retain the prescription c order concerned for a period of not less than five years as from the dat of such sale; a Schedule 6 substance may only be sold if the course of treatmen does not exceed 30 consecutive days: the sale of’ a Schedule 5 or Schedule 6 substance b~ n manufacturer o or uholesale dealer in pharmaceutical products shall be recorded in register which shall be kept in the prescribed manner. and shall bl balanced so as to show clearly the quantity of every Schedule 50 Schedule 6 substance remaining in stock as on the last da> of March June. September and December of each year. and such balancing shal be completed within the 14 days following each of the said dates; a pharmacist shall endorse on the prescription the date of sale and thl quantit} of the substance sold. and When it is repeated. the date of salf and the quantity of the said substance sold. and the last seller shal retain the prescription for a period of not less than five years as fron the date of the last sale: an! Schedule 1, Schedule 2. Schedule 3 or Schedule 4 substance fo the treatment of any animal ma! be supplied by an) person practisin~ a para-veterinary profession within the meaning of the Veterinary anc Para-Veterinary Professions Act. 1982 (Act No, 19 of 1982). upon i vritten prescription issued b~ a veterinarian or on the verbs instructions of a veterinarian. ( 7 ) (a) No person. other than a pharmacist. pharmacist intern 01 pharmacist’s assistant acting under the personal supervision of a pharma. cist. shall sell or export a Schedule 1. Schedule 2, Schedule 3. Schedule 4 Schedule 5 or Schedule 6 substance for analytical purposes. manufacture 01 foods. cosmetics. educational or scientific purposes. unless a permit, issuec in accordance with the prescribed conditions has. subject to paragraph (b). been obtained from the Director-General for such purpose. (b) The Director-General may revoke an+ permit referred to in paragraph (a) if the conditions on which such perrmt was issued. are not complied with o]- if it is not in the public interest that the particular action be continued. (8) Subject to subsection (9). a Schedule 7 substance shall not be acquired b! any person other than the Director-General for [he purpose of providing a medical practitioner therewith. on the prescribed conditions. for the treatment of a particular patient of that medical practitioner upon such conditions as the Director-General. on the recommendation of the council. may determine. (9) (a) No person shall— (i) acquire. use, possess. manufacture. or supply any Schedule 7 substance. or manufacture any Schedule 6 substance unless he or she has been issued with a permit by the Director-General for such acquisition. use, possession. manufacture, or supply: Provided that the Director-General may, subject to such conditions as he or she may determine. acquire or authorise the use of any Schedule 7 substance in order to provide a medical practitioner. analyst, researcher or veterinarian therewith on the prescribed conditions for the treatment or prevention of a medical condition in a particular patient. or for the purposes of education. analysis or research: 5 10 15 10 !5 io 5 0 5 0 5 20 No. I 8505 GO\JERNMENT GAZETTE. 12 DECEMBER 1997 Act NO. !)0. 1997 MEDICINES ,AND RELATED SUBSTANCES CONTROL AMENDMENT ACT. 19YI (ii ) manufacture. use or supply an}’ Schedule 5 or Schedule 6 substance for other than medicinal purposes. unless he or she has been issued by the Director-General with a permit for such manufacture. use or supply upon the prescribed conditions. (b) Notwithstanding paragraph (~). the Director-General may at any time revoke any permit issued in terms of that paragraph if any condition on which the permit was issued is not being complied with. (c) A permit issued in terms of this subsection shall be valid for a period of 12 calendar months after the date of issue thereof. ( 10) Notwithstanding anything to the contrary contained in this section. no person shall sell or administer any Scheduled substance or medicine for other than medicinal purposes: Provided that the Minister may. subject to the conditions or requirements stated in such authority. authorise the administration outside any hospital of any Scheduled substance or medicine for the satisfaction or relief of a habi[ or craving to the person referred to in such authorit}. (11 ) (a) No person shall ‘import or export any Schedule 6 or Schedule 7 substance or other substance or medicine prescribed for that purpose unless a permit has been issued [o him or her b} the Director-General in the prescribed manner and sub]ec[ to the prescribed conditions. (b) A permit referred to in paragraph (u) may be issued for an~ purpose other than the satisfaction or relief of a habi[ or craving in respect of such substance or medicine. (c) The issue of a permit referred to in paragraph (a) may be refused if— (i) the Director-General is not convinced that the applicant is capable of keeping or s[orin~ the substance or medicine in a satisfac[o~ manner in order to preven~ the loss thereof; (ii ) the use of such substance or medicine has not been authorised in terms of this Act; (iii ) the Director-General is of the opinion that the annual importation quota for such substance has been exceeded or will be exceeded: (iv) the Director-General is of the opinion that such substance or medicine. of an acceptable quality. is already available in the Republic: or (v) the applicant did not compl) with the conditions under which a previous permit was issued to him or her. (d) If an application is refused, the applicant shall be furnished with the reasons for such refusal, (e) A permit issued in terms of this subsection shall be valid for a period of six months from the date of issue thereof. (12 ) (a) The control on the importation of Scheduled substances shall relate to-- (i) any Schedule 6 or Schedule 7 substance: (ii ) such substances irrespective of the scheduling status allocated thereto. as the Minister ma} prescribe: (iii ) any other substance which becomes subject to international control in terms of the 1961 Single Convention on Narcotic Drugs or the 1971 Convention on Psychotropic Substances entered into by the Republic. (b) The obtaining of import permits as required in terms of subsection (11 ) shall not apply to an! preparation which contains a substance as prescribed which is specifically exempted from all control measures for the obtaining of such import permits by the 1961 Single Convention on Narcotic Drugs referred to in paragraph (a). (c) Notwithstanding paragraph (b). no such importation shall take place unless authorised by the Director-General. (13 ) Any permit issued under subsection (11) shall be subject— (a) to the applicant’s furnishing the registrar annually with the prescribed information: (b) to the requirement that there shall be no deviation from the particulars reflected on the permit: Provided that if the quantity of such substance or medicine to be imported is less than that provided for in the permit. ??-- No. 18505 GOVERNMENT GAZETTE. 12 DECEMBER 1997 Act No. 90, 1997 MEDICINES ,AND RELATED SUBSTANCES CONTROL AMENDMENT ACT, 1997 the Director-General shall be informed in writing thereof within I ( days after the importation of such substance or medicine; and (c) to the conditions, as detailed on the permit. having been compliet with. the triplicate copy of the permit having been certified by : customs officer or an employee of the S.A. Post Office Limited. ( 14) Notwithstanding anything to the contrary contained in thi: section— (u) a pharmacist’s assistant shall not handle any Schedule 6 substanct except as contemplated in subsection (5)(a) and (b); and (b) no nurse or a person registered under the Health Professions Act. 1974 other than a medical practitioner or dentist, may prescribe a medicine or Scheduled substance unless he or she has been authorised to do sc by his or her professional council concerned, ( 15) Notwithstanding anything to the contrary contained in this section, the Director-General may, after consultation with the Interim Pharmac} Council of South Africa as referred to in section 2 of the Pharmacy Act. 1974 (Act No. 53 of 1974). issue a permit to any person or organisation performing a health service. authorizing such person or organisation to acquire. possess. use or supply any specified Schedule 1. Schedule 2. Schedule 3, Schedule 4 or Schedule 5 substance, and such permit shall be subject to such conditions as the Director-General may determine, ( 16) Notwithstanding anything to the contrary contained in this section— (a) (/?) (c) (d) any person ma] possess a Schedule 0. Schedule 1 or Schedule 2 substance for medicinal purposes: any person may possess a Schedule 3. Schedule 4. Schedule 5. Schedule 6 or Schedule 7 substance if he or she is in possession of a prescription issued by an authorised prescriber; any medicine or scheduled substance may be possessed b~ a medical practitioner. dentist. veterinarian. practitioner, nurse or other person registered under [he Health professions Act. ] 974. or under th e Veterinary and Para-Veterinary Professions Act. 1982. for the pur- poses of administering it in accordance with his or her scope of practice; any medicine or scheduled substance may be possessed for sale bv a pharmacist. a person licenced to own a ph&nacy in terms of ~he Pharmacy Act. 1974, or a person who is the holder of a licence as contemplated in section 22C. (17 ) For the purposes of this section— (a) (b) ‘authorised prescriber’ means a medical practitioner, dentist, veteri- narian. practitioner. nurse or other person registered under the Health Professions Act. 1974: and ‘medicinal purpose’ means for the purposes of the treatment or prevention of a disease or some other definite curative or therapeutic purpose. but does not include the satisfaction or relief of a habit or craving for the substance used or for any other such substance. except where the substance is administered or used in a hospital or similar institution maintained wholly or partly by the Government or a provincial government or approved for such purpose by the Minis- ter.”. 50 Insertion of sections 22C, 22D, 22E, 22F, 22G and 22H in Act 101 of 1965
Part
Schedule 6 or Schedule 7 substance if he or she is in possession of a
- 14 Verify source ↗
The following sections are hereby inserted in the principal Act after section 22B:
AI-assisted research summary: This section lets the Director-General and the council issue certain medicine-related licences, and it prohibits unlicensed compounding, dispensing, manufacturing, wholesaling, or distributing.
14. The following sections are hereby inserted in the principal Act after section 22B: “Licensing 22C. [1) Subject to the provisions of this section— (a) the Director-General may on application in the prescribed manner and I 55 on payment of the prescribed fee issue to a medical practitioner, dentist, practitioner, nurse or other person registered under the Health Professions Act, 1974, a licence to compound and dispense medicines, on the prescribed conditions; 24 No. 18505 GOVERNMENT GAZETTE. 12 DECEMBER 1997 Act No. 90, 1997 MEDICINES AND RELATED SUBSTANCES CONTROL AMENDMENT ACT, 1997 (b) the council may, on application in the prescribed manner and or payment of the prescribed fee, issue to a manufacturer, wholesaler o] distributor of a medicine or medical device a licence to manufacture act as a wholesaler of or distribute. as the case may be, such medicine or medical device, upon such conditions as to the application of such acceptable quality assurance principles and good manufacturing and distribution practices as the council may determine. (~) A li~ence refened to in subsection ( 1 )(a) shall not be issued unless the applicant has successfully completed a supplementary course prescribed under the Pharmacy Act, 1974 (Act No. 53 of 1974), by the Interim Pharmacy Council of South Africa. (3) The Director-General or the council. as the case may be, may require an applicant contemplated in subsection ( 1 ) to furnish such information. in addition to any information furnished by the applicant in terms of the said subsection, as the Director-General or the council may deem necessary. (4) When the Director-General or the council. as the case may be, grants or refuses an application for a licence— (a) written notice shall be given of that fact to the applicant; and (b) in the event of the refusal of an application. the applicant shall be furnished with the reasons for such refusal. (5) No person shall compound or dispense a medicine unless he or she is authorised thereto in terms of the Pharmacy Act, 1974, or is the holder of a Iicence as contemplated in subsection (1 )(u). (6) No manufacturer, wholesaler or distribute referred to in subsection ( 1 )(b) shall manufacture, act as a wholesaler of or distribute, as the case may be, any medicine or medical device unless he or she is the holder of a licence contemplated in the said subsection. (7) Subsections (5) and (6) shall come into operation six months after the commencement of this section. Period of validity and renewal of licence - 22D Verify source ↗
A licence issued under section 22C shall be valid for the prescribed
AI-assisted research summary: Pharmacists must explain generic substitution, record patient refusals and dispensing details, and follow limits on substitution; wholesalers face sourcing and sales restrictions; licence holders may renew licences subject to timing and fees.
22D. A licence issued under section 22C shall be valid for the prescribed period but may be renewed on application in the prescribed manner and before the prescribed time or such later time as the Director-General or the council. as the case may be. may allow and on payment of the prescribed fee, Suspension and cancellation of Iicence 22E. ( 1 ) If the holder of a licence under section 22C— (a) (b) (c) (d) has in or in connection with an application for a licence or renewal of a licence furnished the Director~General or the council, as the case may be. with any information which to the knowledge of such holder is untrue or misleading in any material respect: has contravened or failed to comply with a condition upon which the licence was issued: has contravened or failed to comply with a provision of this Act; has. in the case of a licence issued in terms of section 22C(I )(a), at any time been convicted of an offence which is of such a nature that, in the opinion of the Director-General. it renders him or her unsuitable to compound or dispense medicines. the Director-General or the council. as the case may be. may by way of a notice in writing call upon him or her to show cause within the period specified in the notice, which period shall not be less than 20 days as from the date of the notice. why the Iicence in question should not be suspended or revoked. (2) The Director-General or the council, as the case may be, may after considering the reasons furnished to him or her in terms of subsection (1 )— (a) suspend the licence in question for such period as he or she or the council may determine: or 5 10 15 ~o ~5 }0 35 40 45 50 55 26 No. 18505 GOVERNMENT GAZETTE, 12 DECEMBER 1997 Act No. 90, 1997 MEDICINES AND RELATED SUBSTANCES CONTROL AMENDMENT ACT, 1997 (b) revoke the licence in question. (3) No person shall be entitled to the repayment of any prescribed fee in respect of any application for the granting or renewal of a Iicence if such application has been refused or if the licence has been suspended or revoked. Generic substitution 22F. (1) Subject to subsections (2), (3) and (4), a pharmacist shall— (a) inform all members of the public who visit his or her pharmacy with a prescription for dispensing, of the benefits of the substitution for a branded medicine of an interchangeable multi-source medicine; and (b) dispense an interchangeable multi-source medicine instead of the medicine prescribed by a medical practitioner, dentist, practitioner, nurse or other person registered under the Health Professions Act, 1974, unless expressly forbidden by the patient to do so, (2) If a pharmacist is forbidden as contemplated in subsection(1)(b), that fact shall be noted by the pharmacist on the prescription. (3) When an interchangeable multi-source medicine is dispensed by a pharmacist he or she shall note the brand name or where no such brand name exists, the name of the manufacturer of that interchangeable multi-source medicine in the prescription book. (4) A pharmacist shall not sell an interchangeable multi-source medi- 5 10 cine— (a) if the person prescribing the medicine has written in his or her own hand on the prescription the words ‘no substitution’ next to the item prescribed; (b) if the retail price of the interchangeable multi-source medicine is 25 higher than that of the prescribed medicine; or (() where the product has been declared not substitutable by the council. Pricing committee 22G. (1) The Minister shall appoint such persons as he or she may deem 30 fit to be members of a committee to be known as the pricing committee. (2) The Minister may. on the recommendation of the pricing committee, make regulations— (a) on the introduction of a transparent pricing system for all medicines and Scheduled substances sold in the Republic; (b) on an appropriate dispensing fee to be charged by a pharmacist or by a person licensed in terms of section 22C( 1 )(a). (3) (a) The transparent pricing system contemplated in subsection (2)(a) shall include a single exit price which shall be published as prescribed. and such price shall be the only price at which manufacturers shall sell medicines and Scheduled substances to any person other than the State. (b) No pharmacist or person licensed in terms of section 22C(l)(a) shall sell a medicine at a price greater than the price contemplated in paragraph (a). (c) Paragraph (b) shall not be construed as preventing a pharmacist or person licensed in terms of this Act to charge a dispensing fee as contemplated in subsection C)(b). 35 40 45 I (4) To the members of the pricing committee who are not in the full-time employment of the State ma~ be paid such remuneration and allowances as the Minister, with the concurrence of the Minister of Finance, may 50 determine. Purchase and sale of medicines by wholesalers 22H. (1) (a) No wholesaler shall purchase medicines from any source other than from the original manufacturer or from the primary importer of the finished product. 55 28 No. 18505 GO\~ERNMENT GAZETTE, 12 DECEMBER 1997 Act NO. 90, 1997 MEDICINES AND RELATED SUBSTANCES CONTROL AMENDMENT ACT, 1997 (b) A wholesaler shall sell medicines only into the retail sector. (2) Subsection (1) shall not be construed as preventing the return of medicines for credit purposes only. to the manufacturer or wholesaler from which that medicine was initially obtained. (3) Any wholesaler may in the prescribed manner and on the prescribed conditions be exempted by the Director-General from the provisions of subsection ( 1 ).”. 5 Substitution of section 24 of Act 101 of 1965, as substituted by section 11 of Act 94 of 1991 - 15 Verify source ↗
The following section is hereby substituted for section 24 of the principal Act:
AI-assisted research summary: A person aggrieved by a Director-General or council decision may appeal to an appeal committee, subject to the prescribed period, manner, and fee.
15. The following section is hereby substituted for section 24 of the principal Act: 10 “Appeal against decision of Director-General or council 24. (1 ) Any person aggrieved by a decision of the Director-General or the council, as the case may be, ma)’. within the prescribed period. in the prescribed manner and upon payment of the prescribed fee, appeal against such decision to an appeal committee appointed by the Minister for tbe purposes of the appeal concerned. (2) An appeal committee contemplated in subsection ( 1 ) shall consist of no fewer than three persons: Provided that— (u) the chairperson shall be a person appointed on account of his or her knowledge of the law. with at ieast 10 years experience thereofi (b) the skills of the other two members shall be relevant [o the case concerned; (c) no member shall have a direct or indirect interest in the affairs of the appellant or respondent. (3) The appeal committee may after hearing the appeal— (a) confirm. set aside or vw the relevant decision of the Director-General or the council; and (b) direct the Director-General or the council. as the case may be. to execute the decision of the appeal committee. (4) The decision of the appeal commiuee shall be in writing and a copy thereof shall be furnished to the appellant as well as to the Director-General or the council. as the case may be. (5) To the members of the appeal committee who are not in the full-time employment of the State shall be paid such remuneration and allowances as the Minister. with the concurrence of the Minister of Finance, may determine. (6) An appeal shall iie from any decision of the appeal committee to the High Court.”. 15 ?0 25 30 35 < Amendment of section 28 of Act 101 of 1965, as amended by section 26 of Act 65 of 1974 and section 12 of Act 17 of 1979 $0 - 16 Verify source ↗
Section 28 of the principal Act is hereb~ amended by the substitution for
AI-assisted research summary: This section amends section 28 so that an authorised person may enter certain premises, vehicles, vessels, or aircraft when there is reason to suspect an offence under the Act.
16. Section 28 of the principal Act is hereb~ amended by the substitution for paragraph (a) of subsection (1) of the following paragraph: “(a) enter upon— (i)— (ii)— any place or premises from which a person authorised under this Act to compound and dispense medicines or Scheduled substances or from which the holder of a licence as contemplated in section 22C( 1 )(b) conducts business: or any premises, place, vehicle, vessel or aircraft [at or in which there is or is on reasonable grounds suspected to be any medicine or Scheduled substance] if he or she has reason to suspect that an offence in terms of this Act has been or is being committed at or in such premises, place, vehicle. vessel or aircraft or that an attempt has been made or is being made there to commit such an offence:”. 45 50 Amendment of section 29 of Act 101 of 1965, as amended by section 27 of Act 65 of 1974 and section 12 of Act 94 of 1991 55 - 17 Verify source ↗
Section 29 of the principal Act is hereby amended—
AI-assisted research summary: This section amends section 29 of the principal Act, including the list of conduct that may trigger a contravention under the Act.
17. Section 29 of the principal Act is hereby amended— 30 No, 18505 GOVERNMENT GAZETTE. 12 DECEMBER 1997 Act N(). 90, 1997 MEDICINES AND RELATED SUBSTANCES CONTROL AhlENDMENT ACT. 1997 (a) by the substitution for paragraphs (a), (b), (c), (d), (e) and ~) of the following paragraphs, respectively: ( c ) (b) “(a) obstructs or hinders any inspector in the exercise of his or her powers or the [carrying out] performance of his or her duties under this Act; or contravenes or fails to comply with the provisions of section 14(1). [or section] 18. 18A or 18B: or contravenes the provisions of section 19(1) or fails to comply with a notice issued under section 19(2): or contravenes the provisions of section 20(1); or contravenes or fails to comply with any condition imposed under section 15(7): or fails to comply with any direction given under section 23 or . . contravenes the provisions of [subsection (3) of that] section 23(3): or”; and (d) (e) (f) 5 10 15 (b) b~ the substitution for paragraph (k) of the following paragraph: “(k) contravenes any provision of section 22A, 22C(5) and (6), 22F, X!G or ~~H or contravenes or fails to comply with any condition ~ imposed thereunder:”, .4mendment of section 30 of Act 101 of 1965, as amended by section 28 of Act 65 of 1974 and section 13 of Act 94 of 1991 20 - 18 Verify source ↗
Section 30 of the principal Act is hereby amended—
AI-assisted research summary: A person convicted of an offence under section 29 can be fined up to R40,000, imprisoned for up to 10 years, or both; a magistrate’s court may impose these penalties.
18. Section 30 of the principal Act is hereby amended— (a) b! [he substitution for subsection (1) of the following subsection: “(1 ) An~ person who is convicted of an offence referred to in section 29 shall be liable to a fine [not exceeding R40 000], or to imprisonment for a period not exceeding 10 years [or to both such fine and such imprisonment].”: and (/J) h! [he addition of the following subsection: “(4) Notwithstanding anything to the contrary in any law contained. a magistrate’s court shall be competent to impose anv penalty provided for in this section.”. Amendment of section 31 of Act 101 of 1965. as amended by section 29 of Act 65 of 1974 and section 13 of Act 17 of 1979 - 19 Verify source ↗
Section 31 of the principal Act is hereby amended—
AI-assisted research summary: This section amends Section 31 of the principal Act by deleting paragraph (b) of subsection (1) and deleting subsection (2), and it repeals section 32 of Act 101 of 1965 as amended.
19. Section 31 of the principal Act is hereby amended— (u) bJ the deletion of paragraph (b) of subsection (1): and (b) by the deletion of subsection (2). 25 30 35 Repeal of section 32 of Act 101 of 1965, as amended by section 30 of Act 65 of 1974 - 20 Verify source ↗
Section 32 of the principal ACI is hereby repealed.
AI-assisted research summary: Section 32 of the principal ACI is repealed.
20. Section 32 of the principal ACI is hereby repealed. Insertion of section 33A in Act 101 of 1965 - 21 Verify source ↗
The following section is hereby inserted in the principal Act after section 33:
AI-assisted research summary: The council must manage its funds from specified sources, keep records, have the records audited, and deposit money into a bank account; it may accept unconditional donations and invest unused deposited money.
21. The following section is hereby inserted in the principal Act after section 33: 40 “Funds of council 33A. (1) The funds of the council shall consist of— (a) State funds received through the Department of Health; (b) fees raised and interest on overdue fees; (c) money accruing to the council from any other source. (2) (a) The council may accept money or other goods donated or bequeathed to the council, provided no condition is attached to such donation or bequest; (b) Details of any such donation or bequest shall be specified in the relevant annual report of the council. (3) The council shall utilise its funds for the defrayal of expenses incurred by the council in the performance of its functions under this Act. 45 50 32 No. 18505 GOVERNMENT GAZETTE. 12 DECEMBER 1997 Act NO. 90, 1997 MEDICINES AND RELATED SUBSTANCES CONTROL AhlENDMENT ACT, 1997 (4) The council shall open an account with a bank as defined in section 1(1 ) of the Banks Act, 1990 (Act No. 94 of 1990), and shall deposit in that account all money referred to in subsections ( 1 ) and (2). (5) The council shall keep full and proper records of all money received or expended. of its assets and liabilities and of its financial transactions. 5 (6) The records and annual financial statements referred to in subsection (5). shall be audited by the Auditor-General. (7) The council may invest money which is deposited in terms of subsection (4) and which is not required for immediate use in any manner as it may deem fit. (8) Any money which at the close of the council’s financial year stands to the credit of the council in the account referred to in subsection (4) and money which has been invested in terms of subsection (7), shall be carried forward to the next financial year as a credit in the account of the council.”. 10 Amendment of section 34A of Act 101 of 1965, as inserted by section 2 of Act 19 of 15 1976 and substituted by section 15 of Act 94 of 1991 - 22 Verify source ↗
Section 34A of the principal Act is hereby amended—
AI-assisted research summary: The Minister may authorise the Director-General or another Department of Health officer, in writing, to exercise some of the Minister’s powers and functions under the Act.
22. Section 34A of the principal Act is hereby amended— (a) by the substitution for subsection ( 1 ) of the following subsection: “(1 ) The Minister may in writing authorise the Director-General or any officer of the Department of [National] Health [and Population 20 Development] to exercise any of the powers conferred upon [him] the Minister b! this Act other than the powers referred to in sections 3, 24(1) and 35, or to exercise or perform any of the duties or functions conferred or imposed on the Minister in terms of this Act.”; and tb) by the substitution in subsection (2) for the words “National Health and 25 Population Development” of the word “Health”. Substitution of section 35 of Act 101 of 1965, as substituted by section 31 of Act 65 of 1974. and amended by section 3 of Act 19 of 1976, section 14 of Act 17 of 1979, section 7 of Act 20 of 1981, section 7 of Act 71 of 1991 and section 16 of Act 94 of 1991 30 - 23 Verify source ↗
The following section is hereby substituted for section 35 of the principal Act:
AI-assisted research summary: The Minister may make regulations about medicines, scheduled substances, and medical devices, but must consult the council, and must publish proposed regulations in the Gazette at least 3 months before making them unless a public-interest exception applies.
23. The following section is hereby substituted for section 35 of the principal Act: “Regulations 35. ( 1 ) The Minister may. in consultation with the council. make regula[ions— (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) prescribing the categories of persons by whom application may be made for the registration of any medicine or to whom a certificate of registration may be transfemed; prescribing the forms which shall be used for any application for the regls[ra[ion of any medicine and the particulars w h i c h s h a l l be furnished with any such application (including particulars regarding the method by which the medicine in question or any component of such medicine is manufactured and the premises at which such medicine or any such component is manufactured); providing for the classification of medicines into classes or caWo- ries for the purposes of this Act; prescribing the samples of any medicine and the quantity thereof which shall accompany any application for the registration of a medicine; prescribing the form in which the medicines register shall be kept and the particulars which shall be entered therein in respect of any registered medicine; prescribing the form of any certificate of registration of any medicine; prescribing the circumstances in which, the conditions on which and the persons or categories of persons to whom any medicine or Scheduled substance may be sold; prescribing the manner in which any package containing any medicine or Scheduled substance shall be labelled, packed or sealed; 35 40 45 50 55 3-! N(). I S505 GOVERNMENT GAZETTE. 12 DECEMBER 1997 Act No. w, 1997 NIEDICINES .AND RELATED SUBSTANCES COINTROL AMENDMENT ACT. 19Y7 ( i x ) (x) (xi) (xii (Xlll (xiv (xv (xvi (xvii) ( x v i i i ) ( x i x ) ( x x) (xxi ) (xxii) (xxiii) (xxiv (xxv prescribing the particulars in regard to the use thereof which shall b, furnished with any medicine or Scheduled substance sold. and thl manner in which such particulars shall be furnished: prescribing the particulars which shall appear in any advertisement relating to any medicine or Scheduled substance, or prohibiting tht inclusion of any specified particulars in such advertisement. or thf distribution of any such advertisement to a specified person or ; specified category of persons or to a specified organisation or : specified category of organisations; prescribing the requirements with which any medicine or an! component thereof shall comply in regard to composition. therapeu tic suitability} and effect. purit> or any other property; prescribing the particulars which shall be published in the Ga:erte ir respec[ of any application for registration referred to in sectior 15( II); prescribing the procedure at meetings of the council and of an) committee appointed under section 9 (including the quorum in the case of committees) and the manner in which meetings of an> suck committee shall be called: prescribing the particulars which shall appear on a prescription or m order for a medicine or a Scheduled substance. the number of issue: of a medicine or a Scheduled substance that may be made on an) such specified prescription or order. the manner in which an} suet prescription or order shall be issued and the period for which m! such prescription or order shall be retained: prescribing the forms of licences. registers. prescription books records and other documents which shall be kept or used in respecl oj Scheduled substances. the manner in which they shall be kept. tht particulars which shall be entered therein and the place where and the period for which the} shall be retained: requiring the furnishing of returns. reports and information in respecl of’ Scheduled substances and plants from which any such substance can be extracted. derived. produced or manufactured. and in respeci of an! medicine or other substance of which an) such Schedulec subs[ance is a component; as to [he transshipment or the exportation from or importation intc the Republic of an! Scheduled substance. specifying the ports m places a{ u’hich such substance may be brought into the Republic: authorizing and regulating or restricting the transmission through the Republic of Scheduled substances: prescribing the manner in which packages containing Scheduled substances shall be labelled when imported into or manufactured in the Republic and the persons by whom and the manner in which they shall be kept; authorizing and regulating the purchase. acquisition. keeping or use of preparations of cocaine by managers or persons in charge of factories or workshops in connection with the treatment of eye injuries or for other essential purposes; authorizing and regulating the purchase, acquisition. keeping or use of Scheduled substances by particular persons or categories of persons: authorizing and regulating the possession by persons entering or departing from the Republic of specified quantities of Scheduled substances for personal medicinal use; as to the disposal or destruction of a medicine or a Scheduled substance, and the records which shall be kept in respect thereofi as to the importation. conveyance, keeping. storage. processing and packing of medicines and Scheduled substances. and the manner in which medicines and Scheduled substances shall be kept and controlled in different categories of hospitals; prescribing the methods in accordance with which samples may be taken under this Act and the form of the certificates to be issued by inspectors in respect of such samples; 5 10 15 20 25 30 35 }0 15 jO i5 )0 36 No. 18505 GOVERNhlEh’T GAZETTE. 12 DECENIBER 1997 Act No. 90, 1997 MEDICINES AND RELATED SUBSTANCES CONTROL AMENDMENT ACT. 1997 (xxxii) (xxvi) (xxvii) (xxviii) (xxix) (xxx) (xxxi) prescribing the methods to be employed and the form of tht certificates to be issued in connection with the testing. examination or analysis of samples taken under this Act; authorizing. regulating, controlling. restricting or prohibiting tht registration, manufacture, modification. importation. storage. trans. portation. sale or use of any medical device or class of medics. devices or medicines in respect of its safety. quality and efficacy: with regard to any matter to ensure the safety, quality and efficacy 01 medicines and medical devices; as to the summary seizure and disposal of any Scheduled substance found in the possession or custody of any person not entitled undel this Act to keep or use it; as to the disposal or destruction of a Scheduled substance which has become unfit for use, and the report to be furnished in respecl thereof prescribing the fee to be paid to the registrar in respect of an application for the registration, and in respect of the registration of a medicine. Scheduled substance or medical device. the fee to be paid annually to the registrar in respect of the retention of the registration of a medicine, Scheduled substance or medical device and the date on which such annual fee shall be paid; prescribing the fee payable in respect of the authorisation of the use of unregistered medicines, the issuing of permits and certificates under this Act. the issuing or renewal of any licence under this Act, the performance of inspections to assess the qualit) of medicines. Scheduled substances or medical devices for the purpose of registration and the evaluation of changes to the particulars contained in registers; relating to appeals against decisions of the Director-General or the council: relating to the conditions under which medicines or Scheduled substances may be sold; relating to the repackaging of medicines in patient-read! packs; relating to the safety, quality and etlicacy of any interchangeable multi-source medicine; relating to the scientific. pharmaceutical, clinical and other skills required by a member of the council orb} a member of the executive committee of the council to evaluate the quality, efficacy and safety of medicines; relating to the safety. quality and efficac~ of imported medicines: relating to the control and conduct of clinical trials; with regard to an}’ matter which in terms of this Act shall or may be prescribed: and generally for the efficient carrying out of the objects and purposes of this Act. and the generality of this provision shall not be limited by the preceding paragraphs of this subsection. The Minister shall. not less than three months before any regulation is made under subsection (1), cause the text of such regulation to be published in the Gazette, together with a notice declaring his or her intention to make that regulation and inviting interested persons to furnish him or her with any comments thereon or an! representations they may wish to make in regard thereto. (xIi) (2) (3) The provisions of subsection (2) shall not apply in respect of— (a) any regulation which, after the provisions of that subsection have been complied with, has been amended by the Minister in consequence of comments or representations received by him or her in pursuance of the notice issued thereunder; or (xxxiii) (xxxiv) (xxx\’) (xxxVi) [xxxvii) (xxxviii) (xxxix) (xl) .3x No. 18505 GOVERNMENT GAZETTE. 12 DECEhlBER 1 W)? .Act No. 90, 1997 MEDICINES AND RELATED SL’BSTANCES CONTROL AMENDMENT ACT, 1997 (b) any regulation in respect of which the Minister is. after consultation with the council. of the opinion that the public interest requires it to be made without delay. (4) A regulation under subsection ( 1 )(xxxi) and (xxxii ) shall be made only in consultation with the Minister of Finance. (5) Regulations made under subsection ( 1 )(xi ) may prescribe that any medicine or any component thereof shall comply. with the requirements set out in any publication which in the opinion of the council is generally recognised as authoritative. (6) Regulations may be made under this section in respect of particular medicines or Scheduled substances or classes or categories of medicines or Scheduled substances or in respect of medicines or Scheduled substances other than particular classes or categories of medicines or Scheduled substances. and different regulations may bc so made in respec[ of different medicines or Scheduled substances or different classes or categories of medicines or Scheduled substances. (7) (a) Regulations made under this section may prescribe penalties for an) contravention thereof or failure to comply therewith of a fine. or imprisonment for a period not exceeding 10 years. (b) Notwithstanding anything to the contrary in an~ law contained a magistrate’s court shall be competent to impose any penalty provided for in paragraph (a). (8) Notwithstanding the provisions of subsection ( 1 ). the Minister ma}. if he or she deems it to be in the public interest, after consultation with the executive committee appointed under section 9. make regulations relating to an! matter referred to in subsection ( 1 ) or amend or repeal any regulation made in terms of that subsection.”. Repeal of section 37 of Act 101 of 1965, as substituted by section 18 of Act 94 of 1991 - 24 Verify source ↗
Section 37 of the principal Act is hereby repealed.
AI-assisted research summary: Section 37 of the principal Act is repealed.
24. Section 37 of the principal Act is hereby repealed. Substitution of section 37A of Act 101 of 1965. as inserted by section 34 of Act 65 of 30 1974 - 25 Verify source ↗
The lollouin: section is hereb) substituted for sec[ion 37A of the principal Act:
AI-assisted research summary: The Minister may amend schedules by Gazette notice, but only on the council’s recommendation.
25. The lollouin: section is hereb) substituted for sec[ion 37A of the principal Act: “’Amendment of Schedules 37A. [The] Notwithstanding the provisions of section 35(2). the Minister may. on the recommendation of the council. from time to time b}’ notice in .35 the Ga:erre amend any Schedule [to this Act] prescribed under section ~2A(~) b, the inclusion therein 01- the deletion therefrom of an~’ medicine or other substance. or in an! other manner.”. Insertion of section 39 in Act 101 of 1965 - 26 Verify source ↗
The following section is hereby inserted in the principal Act after section 38: 40
AI-assisted research summary: This provision inserts a new section 40 after section 38 in the principal Act.
26. The following section is hereby inserted in the principal Act after section 38: 40 “State bound - 39 Verify source ↗
This Act binds the State.”’.
AI-assisted research summary: This Act applies to and binds the State.
39. This Act binds the State.”’. Repeal of Schedules to Act 101 of 1965, as added by section 36 of Act 65 of 1974 27. ( I ) Subject to subsection (2). Schedules 1 up to and including Schedule 9 of the principal Act are hereby repealed. 45 (2) Any reference in any law or document to an~ medicine or other substance referred to in any Schedule to the principal Act prior to the date of commencement of subsection (1) shall be construed from that date as a reference to the corresponding medicine or 40 No. 18505 GOVERNMENT GAZETTE, 12 DECEMBER 1997 Act No. 90, 1997 MEDICINES AND RELATED SUBSTANCES CONTROL AMENDMENT ACT, 1997 other substance prescribed by the Minister under section 22A of the principal Act, as substituted by section 13 of this Act. Substitution of section 40 of Act 101 of 1965 - 28 Verify source ↗
The following section is hereby substituted for section 40 of the principal Act:
AI-assisted research summary: Section 28 substitutes a new section 40 into the principal Act.
28. The following section is hereby substituted for section 40 of the principal Act: “Short title 5 - 40 Verify source ↗
This Act shall be called the Medicines and Related Substances
AI-assisted research summary: This section gives the Act its short title: the Medicines and Related Substances [Control] Act, 1965.
40. This Act shall be called the Medicines and Related Substances [Control] Act, 1965.”. Substitution of long title of Act 101 of 1965, as substituted by section 22 of Act 94 of 1991 - 29 Verify source ↗
The following long title is hereby substituted for the long title of the principal Act:
AI-assisted research summary: This section replaces the principal Act’s long title and states that several sections of Act 94 of 1991 are repealed.
29. The following long title is hereby substituted for the long title of the principal Act: 10 “ACT To provide for the registration of medicines intended for human and for animal use; for the registration of medical devices; for the establishment of a Medicines Control Council; for the control of medicines. Scheduled substances and medical devices; for the control of manufacturers. wholesalers and distributors of medicines and medical devices; and for the control of persons who may compound and dispense medicines; and for matters incidental thereto.’”. Repeal of sections 9, 16(c) up to and including (h), 19,21,23,24 and 25 of Act 94 of 1991 - 30 Verify source ↗
Sections 9, 16(c) up to and including (h), 19, 21, 23.24 and 25 of the Medicines
AI-assisted research summary: This section repeals specified sections of the Medicines and Related Substances Control Amendment Act, 1991.
30. Sections 9, 16(c) up to and including (h), 19, 21, 23.24 and 25 of the Medicines and Related Substances Control Amendment Act. 1991 (Act No. 94 of 1991). are hereby repealed. Repeal of laws - 31 Verify source ↗
The laws mentioned in the Schedule are hereby repealed to the extent set out in the
AI-assisted research summary: This section repeals the Schedule-listed laws, but only to the extent stated in the Schedule and only for the former listed Republics and self-governing territories.
31. The laws mentioned in the Schedule are hereby repealed to the extent set out in the third column thereof, to the extent to which those laws formed a part of the legislation of the areas of the forrner— (a) Republics of Transkei. Bophuthatswana. Venda and Ciskei; and (b) self-governing territories of Lebowa. @zankulu, Qwawa. Kw~ulu. KwaNdebele and KaNgwane in terms of the Self-governing Territories Constitution Act, 1971 (Act No. 21 of 1971). Extension of application of Act 101 of 1965 - 32 Verify source ↗
The Medicines and Related Substances Act. 1965. and all amendments thereof,
AI-assisted research summary: This section says the Medicines and Related Substances Act, 1965, and its amendments apply throughout the Republic.
32. The Medicines and Related Substances Act. 1965. and all amendments thereof, 15 20 25 30 shall apply throughout Republic. Short title and commencement - 33 Verify source ↗
This Act shall be called the Medicines and Related Substances Control
AI-assisted research summary: This section gives the Act its short title and says it starts on a date fixed by the President by proclamation in the Gazette.
33. This Act shall be called the Medicines and Related Substances Control Amendment Act, 1997, and shall come into operation on a date fixed by the President by proclamation in the Gazette. 35 ~~ No. 18505 GOVERNMENT GAZETTE, 12 DECEMBER 1997 A c t No. 9 0 . 1 9 9 7 MEDICINES AND RELATED SUBSTANCES CONTROL AMENDMENT ACT. 1997 SCHEDULE (Section 31) No. and year of law Short title Extent of repeal Ac( No. 101 of 1965 Medicines and Related Substances Control Act. 1965 Act Nc). 2?9 of 1968 Drugs Control Amendment Act. 1968 Act No. 88 Of 1 9 7 0 Drugs Control Amendmerr~ Act, 1970 ACT No. 95 of 1971 Drugs Laws Amendment Act. 1971 The whole The whole The whole Section 7 Ac( No. 65 of 1974 Drugs Control Amendment Ac{, 1974 Sections I up to and in- ACI NCI. 19 of 1976 Medmnes and Re)a[ed Substances Conmol Amendment Acl, 1976 Ac( No. 36 of 1977 Health Laws Amendmen( Ac[. 1977 Act No 17 of 1979 Med!clnes and Related Subs[mrces Con[ml Act No 20 of 1981 Amendmen[ ACI, [ 979 Medicines and Related Substances Control Amendment Act. 1981 ACI No. 71 of 1991 Businesses Act. 1991 cluding 37 The whole Section 1 The whole The whole Items I and 2 as they appear m column 3 of Schedule 3 opposi[e Act No. 101 of 1965 Act N(). W Ot 1991 Medlclnes and Related Substances Control Sections 1 up to and Amendment Ac(, 1991 including 22 Transke] Act N(I. 27 of 1978 Mechclnes md Related Substances Comrol Act, 1978 The whole
Provision text is displayed from LexChat’s stored statute record. Use the official source links to verify amendments, commencement, and current legal force.
Ask AI about this statute
Medicines and Related Substances Control Amendment Act
Sign in to ask AI about this statute
Sign in to start authenticated, citation-grounded statute research.
Sign in